GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmunityBio Inc (STU:26CA) » Definitions » Accounts Payable

ImmunityBio (STU:26CA) Accounts Payable : €12.76 Mil (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is ImmunityBio Accounts Payable?

ImmunityBio's Accounts Payable for the quarter that ended in Mar. 2024 was €12.76 Mil.

ImmunityBio's quarterly Accounts Payable declined from Sep. 2023 (€18.57 Mil) to Dec. 2023 (€8.43 Mil) but then increased from Dec. 2023 (€8.43 Mil) to Mar. 2024 (€12.76 Mil).

ImmunityBio's annual Accounts Payable increased from Dec. 2021 (€10.11 Mil) to Dec. 2022 (€19.84 Mil) but then declined from Dec. 2022 (€19.84 Mil) to Dec. 2023 (€8.43 Mil).


ImmunityBio Accounts Payable Historical Data

The historical data trend for ImmunityBio's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ImmunityBio Accounts Payable Chart

ImmunityBio Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Accounts Payable
- 9.46 10.11 19.84 8.43

ImmunityBio Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 31.36 23.53 18.57 8.43 12.76

ImmunityBio Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.


ImmunityBio Accounts Payable Related Terms

Thank you for viewing the detailed overview of ImmunityBio's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


ImmunityBio (STU:26CA) Business Description

Traded in Other Exchanges
Address
3530 John Hopkins Court, San Diego, CA, USA, 92121
ImmunityBio Inc is a late-clinical-stage immunotherapy company developing next-generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. Geographically, the company operates in United States and Europe. Majority of the revenue is generated from Europe.

ImmunityBio (STU:26CA) Headlines

No Headlines